Harry Alcorn
Impact in
- Nephrology top 2%
- Dialysis and Renal Disease Management
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Antibiotic Resistance in Bacteria 4
-
- Antibiotics Pharmacokinetics and Efficacy 7
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- Charles J. McAllisterSander GreenlandJoel D. KoppleKamyar Kalantar‐ZadehNoriko KuwaeRyan D. KilpatrickSteve FullerHenry R. Shinefield
- Journals
- The Journal of Clinical Pharmacology (6 papers)Antimicrobial Agents and Chemotherapy (2 papers)Journal of the American Geriatrics Society (1 paper)Clinical Journal of the American Society of Nephrology (1 paper)Journal of Pain (1 paper)
- Partner nations
- United StatesIndiaUnited Kingdom
In The Last Decade
Harry Alcorn
28 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 106
- Nephrology 340
- Infectious Diseases 439
- Hepatology 133
- Occupational Therapy 64
- Clinical Biochemistry 96
Countries citing papers authored by Harry Alcorn
This map shows the geographic impact of Harry Alcorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Alcorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Alcorn more than expected).
Fields of papers citing papers by Harry Alcorn
This network shows the impact of papers produced by Harry Alcorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Alcorn. The network helps show where Harry Alcorn may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Harry Alcorn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 27 | |
| 2 | 2018 | 14 | |
| 3 | 2017 | 28 | |
| 4 | 2017 | 1 | |
| 5 | 2017 | 31 | |
| 6 | 2015 | 50 | |
| 7 | 2014 | 43 | |
| 8 | 2014 | 49 | |
| 9 | 2013 | 20 | |
| 10 | 2011 | 1 | |
| 11 | 2010 | 22 | |
| 12 | 2010 | 35 | |
| 13 | 2010 | 7 | |
| 14 | 2008 | 1 | |
| 15 | 2006 | 12 | |
| 16 | 2006 | 19 | |
| 17 | 2005 | 280 | |
| 18 | 2003 | 32 | |
| 19 | 2002 | 351 | |
| 20 | 2000 | 76 |
About Harry Alcorn
Harry Alcorn is a scholar working on Molecular Medicine, Pharmacology, Pharmacology, Nephrology and Infectious Diseases, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Antibiotic Resistance in Bacteria (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), HIV/AIDS drug development and treatment (3 papers), Pharmaceutical studies and practices (3 papers), Hepatitis C virus research (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). The work is most often cited by research in Nephrology (340 citations), Infectious Diseases (439 citations), Hepatology (133 citations), Occupational Therapy (64 citations) and Clinical Biochemistry (96 citations). Harry Alcorn has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Charles J. McAllister, Sander Greenland, Joel D. Kopple, Kamyar Kalantar‐Zadeh, Noriko Kuwae, Ryan D. Kilpatrick, Steve Fuller, Henry R. Shinefield, Gary Horwith and Rachel Schneerson. Their work appears in journals such as The Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy, Journal of the American Geriatrics Society, Clinical Journal of the American Society of Nephrology and Journal of Pain.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.